lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: lannett company, inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
lannett company, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0527-4662
Product ID
0527-4662_7ac942a6-689a-420b-87bf-dc59003400dc
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA215802
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2023-08-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05274662
Hyphenated Format
0527-4662
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA215802 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (0527-4662-37)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7ac942a6-689a-420b-87bf-dc59003400dc", "openfda": {"upc": ["0305274664379", "0305274666373", "0305274661378", "0305274665376", "0305274667370", "0305274663372"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0527-4662-37)", "package_ndc": "0527-4662-37", "marketing_start_date": "20230825"}], "brand_name": "Lisdexamfetamine Dimesylate", "product_id": "0527-4662_7ac942a6-689a-420b-87bf-dc59003400dc", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "0527-4662", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine Dimesylate", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine Dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA215802", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}